Intracystic Papillary Carcinoma of Breast Harbors Significant Genomic Alteration Compared with Intracystic Papilloma: Genome-wide Copy Number and LOH Analysis Using High-Density Single-Nucleotide Polymorphism Microarrays
Authors:
- 9 June 2011
- journal article
- Published by Hindawi Limited in The Breast Journal
- Vol. 17 (4) , 427-430
Abstract
Purpose: Intracystic papillary breast tumors consist of benign papilloma, carcinoma in situ and carcinoma with invasion. Using high-density single-nucleotide polymorphism arrays, this study aimed to determine the profile of genomic alterations in these lesions and to identify novel diagnostic criteria. Methods: Ten samples of intracystic papillary tumor, which included five papillomas (Pap), three papillary carcinomas in situ (PurePC) and two papillary carcinomas with invasion (PCinv), were studied. DNA was extracted from tumor and normal tissues that were microdissected from the same formalin-fixed paraffin embedded blocks. Using probe intensity and genotype data from high-density oligonucleotide SNP microarrays (AffymetrixR GeneChip Genome-wide Human 5.0), paired copy number and LOH analysis was performed using Partek Genomic Suite Software. Results: Quality control (QC) call rate, which is an index measuring the quality of a SNP microarray experiment, ranged from 70.75% to 91.93%, mean 80.72%. The mean total genomic alteration rate (sum of amplifications, deletions and copy-neutral loss of heterogeneity) with respect to the whole genome was 2.87%, 15.4% and 35.3% in Pap, PC and IDC, respectively, and was significantly different between samples (Kruskal-Wallis chi-squared test, p = 0.043). The most commonly altered regions (. 4/5) in papillary carcinoma were copy-neutral loss of heterogeneity at 3p21.31 and 3p14.2 and amplification at 20q13.13. Genes altered only in invasive carcinoma included genes concerned with transcription. Conclusions: Among intracystic papillary breast tumors, malignant tumors, including non-invasive tumors, which are difficult to diagnose histopathologically, harbor significant genomic alteration. Our findings may aid clinical management of these tumors and may provide insight into their carcinogenesisKeywords
This publication has 9 references indexed in Scilit:
- Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for Routine Clinical Use on Formalin-fixed Paraffin-embedded TissuesDiagnostic Molecular Pathology, 2008
- Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapyThe American Journal of Surgery, 2007
- Genome-Wide, High-Resolution Detection of Copy Number, Loss of Heterozygosity, and Genotypes from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using MicroarraysCancer Research, 2007
- Papillary lesions of the breast: a molecular progression?Breast Cancer Research and Treatment, 2005
- Treatment and outcome of patients with intracystic papillary carcinoma of the breastThe American Journal of Surgery, 2002
- Diagnostic difficulty arising from displaced epithelium after core biopsy in intracystic papillary lesions of the breastJournal of Clinical Pathology, 2002
- Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high‐molecular‐weight cytokeratin expression patternsThe Journal of Pathology, 2001
- Pattern of Chromosome 16q Loss Differs between an Atypical Proliferative Lesion and an Intraductal or Invasive Ductal Carcinoma Occurring Subsequently in the Same Area of the BreastLaboratory Investigation, 2001
- Loh at 16p 13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breastHuman Pathology, 1998